Kopran Limited (NSE:KOPRAN)
194.01
+9.23 (5.00%)
Jun 19, 2026, 3:29 PM IST
Kopran Market Cap
Kopran has a market cap or net worth of 9.4 billion as of June 18, 2026. Its market cap has increased by 6.48% in one year.
Market Cap
9.40B
Enterprise Value
10.85B
Revenue
6.81B
Ranking
n/a
PE Ratio
36.52
Stock Price
194.01
Market Cap Chart
Since April 1, 2002, Kopran's market cap has increased from 572.00M to 9.40B, an increase of 1,542.72%. That is a compound annual growth rate of 12.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 9.40B | 29.82% |
| Dec 31, 2025 | 7.24B | -29.34% |
| Dec 31, 2024 | 10.24B | -11.98% |
| Dec 29, 2023 | 11.64B | 60.08% |
| Dec 30, 2022 | 7.27B | -48.06% |
| Dec 31, 2021 | 14.00B | 132.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.38T |
| Divi's Laboratories | 1.80T |
| Apollo Hospitals Enterprise | 1.21T |
| Cipla | 1.09T |
| Laxmi Dental | 12.26B |
| GPT Healthcare | 12.04B |
| Remus Pharmaceuticals | 9.65B |
| Accent Microcell | 9.57B |